<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSM1217734"><item key="PPARD TREATMENT">PPAR&#206;&#178;/&#206;&#180; agonist</item><item key="OXYGEN CONDITION">normoxia</item></item></item><item><item key="GSM1217733"><item key="PPARD TREATMENT">PPAR&#206;&#178;/&#206;&#180; agonist</item><item key="OXYGEN CONDITION">hypoxia</item></item></item><item><item key="GSM1217732"><item key="PPARD TREATMENT">DMSO</item><item key="OXYGEN CONDITION">normoxia</item></item></item><item><item key="GSM121773"><item key="PPARD TREATMENT">DMSO</item><item key="OXYGEN CONDITION">hypoxia</item></item></item></item><item key="id">2104</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">Recently the role of PPAR&#946;/&#948; in angiogenesis has been revealed, and we hypothesized that the crosstalk between hypoxia and PPAR&#946;/&#948; on...</item><item key="geo_gse_id">E-GEOD-50378</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">4</item><item key="tags"/><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-of-huvec-cells-after-ppar-agonist</item><item key="geo_id_plat">E-GEOD-50378_A-AFFY-44</item><item key="name">Expression data of HUVEC cells after PPAR&#946;/&#948; agonist and/or hypoxia treatment</item><item key="created">Jul.11, 2014</item><item key="summary">Recently the role of PPAR&#946;/&#948; in angiogenesis has been revealed, and we hypothesized that the crosstalk between hypoxia and PPAR&#946;/&#948; on endothelial cells may exsist. To elucidate the interaction between two signalings, we report the comprehensive change of transcripts induced by PPAR&#946;/&#948; agonist (GW501516) and/or hypoxia. We used microarray analysis of HUVECs treated with PPAR&#946;/&#948; agonist (GW501516) and/or hypoxia (1% O2) for 24-hours, and we identified a group of consistently up- or down-regulated genes. HUVECs were used within the first 6 passages. HUVECs were treated with PPAR&#946;/&#948; agonist (GW501516) at a concentration of 100 nM and/or hypoxia (1% O2) for 24-hours. Same concentration of DMSO was used as a control sample, and as to the oxgen, normoxia was used as a control condition.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50378</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50378/samples/</item></data></biogps>
